Randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202).
   Google Scholar   
Citation:
J Clin Oncol vol 37 (Suppl) abstr 4005
Meeting Instance:
ASCO 2019
Year:
2019
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10CA180863 (CCTG); U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                           
Networks:
ADM400, ADM402, ADM403, ALLIANCE, CA136, COLUMBIA, FL065, LAB254, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, LAPS-NY016, LAPS-OH007, VA002   
Study
A021202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: